Foster Dykema Cabot & Partners’s Eli Lilly LLY Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.8M	Sell	28,073 -44	-0.2%	-$44.6K	1.64%	18
2025 Q4	$30.2M	Sell	28,117 -1,962	-7%	-$1.88M	1.86%	14
2025 Q3	$22.9M	Sell	30,079 -120	-0.4%	-$89.3K	1.51%	24
2025 Q2	$23.5M	Sell	30,199 -824	-3%	-$640K	1.66%	21
2025 Q1	$25.6M	Sell	31,023 -2,537	-8%	-$2.11M	2.06%	17
2024 Q4	$25.9M	Sell	33,560 -9,163	-21%	-$7.59M	2.02%	16
2024 Q3	$37.9M	Sell	42,723 -1,016	-2%	-$913K	3.18%	7
2024 Q2	$39.6M	Sell	43,739 -212	-0.5%	-$170K	3.54%	6
2024 Q1	$34.2M	Sell	43,951 -5,497	-11%	-$3.91M	3.18%	6
2023 Q4	$28.8M	Buy	+49,448	New	+$28.9M	3.05%	6

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Foster Dykema Cabot & Partners's LLY Position: Q1 2026 in Review

Foster Dykema Cabot & Partners reduced its Eli Lilly (LLY) stake by 0.16% in Q1 2026, selling an estimated $44.6K and leaving 28,073 shares worth $25.8M. The position accounts for 1.64% of the portfolio, ranked #18.

Foster Dykema Cabot & Partners first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $39.6M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Foster Dykema Cabot & Partners held 28,073 shares of Eli Lilly worth $25.8M as of Q1 2026.
Foster Dykema Cabot & Partners sold 44 Eli Lilly shares in Q1 2026, an estimated $44.6K.
Eli Lilly made up 1.64% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #18 holding.
Foster Dykema Cabot & Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
Foster Dykema Cabot & Partners's Eli Lilly position peaked at $39.6M in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.